Department of Urologic Oncology
Tianjin Medical University Cancer Institute & Hospital, Tianjin
泌尿肿瘤科 · Medical Oncology
The Department of Urologic Oncology treats tumors of the urinary and reproductive systems, including kidney, adrenal, bladder, ureter, prostate, testicular, and penile cancers, as well as retroperitoneal tumors. The department combines traditional radical surgeries with minimally invasive techniques, such as laparoscopic surgery and transurethral resection. It also performs organ-preserving procedures, including partial nephrectomy and bladder-sparing surgery supported by neoadjuvant therapy. Treatment plans often integrate radiation, chemotherapy, biological therapy, and targeted therapy. The department reports that its standardized approach has reduced the five-year recurrence and metastasis rate for bladder cancer to under 30 percent and increased the five-year survival rate for post-operative kidney cancer patients to 88 percent.
What the department treats
- Treatment of kidney, bladder, prostate, and other urologic cancers
- Minimally invasive laparoscopic urologic surgery
- Transurethral resection for bladder cancer
- Organ-preserving surgeries, including partial nephrectomy
- Bladder-sparing surgery with neoadjuvant therapy
- Integrated radiation, chemotherapy, and targeted therapy
Key facts
- The department has 69 inpatient beds.
- Annual outpatient volume is approximately 6,000 visits, with over 1,000 patients admitted and more than 500 surgeries performed each year.
- The department originated from the Pelvic and Urologic Oncology Division established in 1952.
As described by the hospital.
Team
12 doctors listed, including 3 chief physicians. Its chief physicians have 15 first- or senior-author papers on PubMed since 2016.
| Chief physician | Clinical focus | Key papers since 2016 |
|---|---|---|
| Prof. Xin Yao 姚欣 · Professor | Surgical treatment of urinary tract tumors, including minimally invasive and robotic surgery. Comprehensive care involving chemotherapy and endocrine therapy for kidney, bladder, and prostate cancers. | 10 |
| Dr. Qing Yang 杨庆 · Associate Professor | Diagnosis and treatment of adrenal, kidney, bladder, prostate, testicular, and penile tumors. Focus on minimally invasive laparoscopic surgery and comprehensive management of prostate cancer. | 3 |
| Dr. Xusheng Chen 陈旭升 | Minimally invasive and robotic surgery for bladder, prostate, kidney, adrenal, and ureteral tumors. Comprehensive treatment for advanced urothelial carcinoma, metastatic prostate cancer, and advanced kidney cancer. | 2 |
Associate chief physicians
- Dr. Jun Du杜君
- Dr. Kun Wang王坤
We are an independent coordination service, not part of this hospital. Team data comes from public doctor-listing platforms; publication counts come from PubMed, matched by full name and affiliation, and doctors with very common names are checked by hand before their papers are shown. How we build this directory.
Not sure which specialist is right?
Send your records. We find a specialist in the right field to review your case and write a treatment plan with a cost estimate.
Get a specialist opinion